Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Move Over Gluten, Fructan in Food May be to Blame for Digestive Distress

By Joanne Van Zuidam | November 14, 2017

Will fructan-free be the next food trend? If a new study holds true, fructan, a carbohydrate found in wheat, will replace gluten as the guilty party in causing digestive distress in those with non-celiac wheat sensitivity.

After a 2013 study of people with non-celiac wheat sensitivity who ate gluten-free revealed no difference in symptoms after eating identical meals that either had gluten or were gluten-free, researchers looked at the carb as a possible culprit.

In the new study, researchers from the University of Oslo in Norway and Monash University in Australia have found evidence that the familiar complaint of bloating after eating foods with wheat may be due to fructan, not gluten.

Here’s the thing: Foods with gluten often contain fructans, so it’s hard to tell what’s to blame.

To find out, the researchers performed a double-blind crossover challenge of 59 non-celiac individuals on a self-instituted gluten-free diet. Participants were randomly assigned to groups placed on muesli bar diets containing gluten (5.7 g), fructans (2.1 g), or placebo, for seven days.

Following a minimum seven-day washout period (until the symptoms induced by the previous challenge were resolved), participants crossed over into a different group, until they completed all three challenges (gluten, fructan, and placebo).

Symptoms were measured by gastrointestinal symptom rating scale irritable bowel syndrome (GSRS-IBS) version using a linear mixed model for analysis.

Overall, GSRS-IBS scores for participants consuming fructans was significantly higher than participants consuming gluten. There was no difference between those who experienced symptoms on the placebo bars and those who ate the gluten bars.

Researchers notes this is an important discovery since some research has shown that following a gluten-free diet may put people at an increased risk of developing type 2 diabetes.

As much as 13 percent of the population have a gluten sensitivity. The reaction to gluten does not damage the cells of the intestines, however it causes similar symptoms, such as abdominal pain, bloating, headaches, “foggy mind,” fatigue, and depression.

In patients with the sensitivity, removing the protein from the diet resolves the symptoms. But if going gluten-free doesn’t resolve these issues, what will? A low-FODMAP diet (FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols.) The diet eliminates bread products with fructans as well as other sources of the carbohydrate, such as onions, garlic, asparagus, and some other vegetables, in addition to other short chain carbohydrates that are poorly absorbed by the small intestine.

The research was published in Gastroenterology.

Related Articles Read More >

How Prelude and QDX are using quantum chemistry to discover cancer treatments
US political drama is pushing life sciences talent toward Switzerland, Basel leader says
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub
AUTOMA+ 2025 brings global pharma expertise to Austria
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE